While multiple studies have also found that semaglutide reduces the risk of death
New research suggests the anti-obesity drug Ozempic could slow down ageing.
Multiple studies have also found semaglutide reduces the risk of death in people who are obese and have heart disease without diabetes.
Participants who took the drug died at a lower rate from all causes - in a study of over 17 thousand over 45s.

Harris Opens Door To Further Delay In Carbon Tax Increase
McEntee Defiant On Border Poll As UK Foreign Secretary Refuses To Comment Publicly
HSE Fined €645K For Personal Data Breaches
Government To Sign Regulations For New E-Scooters Measures
Fórsa Members Vote Overwhelmingly For Industrial Action Amid Pay Dispute
National Youth Council Calls On Government To Take Action To Curb Emigration
Man Dies After Violent Disorder Incident In Leopardstown Over The Weekend
New Scheme Allows Smaller Drug Offenders To Be Referred To HSE Rather Than Prosecuted